116 related articles for article (PubMed ID: 22147973)
1. Pancreatic cancer risk variant ABO rs505922 in patients with cholangiocarcinoma.
Krawczyk M; Mihalache F; Höblinger A; Acalovschi M; Lammert F; Zimmer V
World J Gastroenterol; 2011 Nov; 17(41):4640-2. PubMed ID: 22147973
[TBL] [Abstract][Full Text] [Related]
2. A common variant in the precursor miR-146a sequence does not predispose to cholangiocarcinoma in a large European cohort.
Mihalache F; Hoblinger A; Acalovschi M; Sauerbruch T; Lammert F; Zimmer V
Hepatobiliary Pancreat Dis Int; 2012 Aug; 11(4):412-7. PubMed ID: 22893469
[TBL] [Abstract][Full Text] [Related]
3. Association between ABO gene polymorphism (rs505922) and cancer risk: a meta-analysis.
Duan YF; Zhu F; Li XD; An Y; Zhang H; Zhou Y; Zhang X; Jiang Y
Tumour Biol; 2015 Jul; 36(7):5081-7. PubMed ID: 25656610
[TBL] [Abstract][Full Text] [Related]
4. Relationships between the ABO blood group SNP rs505922 and breast cancer phenotypes: a genotype-phenotype correlation study.
Rummel S; Shriver CD; Ellsworth RE
BMC Med Genet; 2012 May; 13():41. PubMed ID: 22642827
[TBL] [Abstract][Full Text] [Related]
5. Association of ABO polymorphisms and pancreatic Cancer/ Cardiocerebrovascular disease: a meta-analysis.
Li Y; Liu L; Huang Y; Zheng H; Li L
BMC Med Genet; 2020 Feb; 21(1):41. PubMed ID: 32093636
[TBL] [Abstract][Full Text] [Related]
6. ABO blood group alleles and the risk of pancreatic cancer in a Japanese population.
Nakao M; Matsuo K; Hosono S; Ogata S; Ito H; Watanabe M; Mizuno N; Iida S; Sato S; Yatabe Y; Yamao K; Ueda R; Tajima K; Tanaka H
Cancer Sci; 2011 May; 102(5):1076-80. PubMed ID: 21306478
[TBL] [Abstract][Full Text] [Related]
7. Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium.
Wolpin BM; Kraft P; Xu M; Steplowski E; Olsson ML; Arslan AA; Bueno-de-Mesquita HB; Gross M; Helzlsouer K; Jacobs EJ; LaCroix A; Petersen G; Stolzenberg-Solomon RZ; Zheng W; Albanes D; Allen NE; Amundadottir L; Austin MA; Boutron-Ruault MC; Buring JE; Canzian F; Chanock SJ; Gaziano JM; Giovannucci EL; Hallmans G; Hankinson SE; Hoover RN; Hunter DJ; Hutchinson A; Jacobs KB; Kooperberg C; Mendelsohn JB; Michaud DS; Overvad K; Patel AV; Sanchéz MJ; Sansbury L; Shu XO; Slimani N; Tobias GS; Trichopoulos D; Vineis P; Visvanathan K; Virtamo J; Wactawski-Wende J; Watters J; Yu K; Zeleniuch-Jacquotte A; Hartge P; Fuchs CS
Cancer Epidemiol Biomarkers Prev; 2010 Dec; 19(12):3140-9. PubMed ID: 20971884
[TBL] [Abstract][Full Text] [Related]
8. Associations between ABO blood groups and pancreatic ductal adenocarcinoma: influence on resection status and survival.
El Jellas K; Hoem D; Hagen KG; Kalvenes MB; Aziz S; Steine SJ; Immervoll H; Johansson S; Molven A
Cancer Med; 2017 Jul; 6(7):1531-1540. PubMed ID: 28556564
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic cancer risk is modulated by inflammatory potential of diet and ABO genotype: a consortia-based evaluation and replication study.
Antwi SO; Bamlet WR; Pedersen KS; Chaffee KG; Risch HA; Shivappa N; Steck SE; Anderson KE; Bracci PM; Polesel J; Serraino D; La Vecchia C; Bosetti C; Li D; Oberg AL; Arslan AA; Albanes D; Duell EJ; Huybrechts I; Amundadottir LT; Hoover R; Mannisto S; Chanock SJ; Zheng W; Shu XO; Stepien M; Canzian F; Bueno-de-Mesquita B; Quirós JR; Zeleniuch-Jacquotte A; Bruinsma F; Milne RL; Giles GG; Hébert JR; Stolzenberg-Solomon RZ; Petersen GM
Carcinogenesis; 2018 Jul; 39(8):1056-1067. PubMed ID: 29800239
[TBL] [Abstract][Full Text] [Related]
10. Potential genotype-specific single nucleotide polymorphism interaction of common variation in p53 and its negative regulator mdm2 in cholangiocarcinoma susceptibility.
Zimmer V; Höblinger A; Mihalache F; Assmann G; Acalovschi M; Lammert F
Oncol Lett; 2012 Jul; 4(1):101-106. PubMed ID: 22807971
[TBL] [Abstract][Full Text] [Related]
11. Association between variants in inflammation and cancer-associated genes and risk and survival of cholangiocarcinoma.
Chaiteerakij R; Juran BD; Aboelsoud MM; Harmsen WS; Moser CD; Giama NH; Allotey LK; Mettler TA; Baichoo E; Zhang X; Therneau TM; Lazaridis KN; Roberts LR
Cancer Med; 2015 Oct; 4(10):1599-602. PubMed ID: 26276523
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis.
Clements O; Eliahoo J; Kim JU; Taylor-Robinson SD; Khan SA
J Hepatol; 2020 Jan; 72(1):95-103. PubMed ID: 31536748
[TBL] [Abstract][Full Text] [Related]
13. ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium.
Rizzato C; Campa D; Pezzilli R; Soucek P; Greenhalf W; Capurso G; Talar-Wojnarowska R; Heller A; Jamroziak K; Khaw KT; Key TJ; Bambi F; Landi S; Mohelnikova-Duchonova B; Vodickova L; Büchler MW; Bugert P; Vodicka P; Neoptolemos JP; Werner J; Hoheisel JD; Bauer AS; Giese N; Canzian F
Oncol Rep; 2013 Apr; 29(4):1637-44. PubMed ID: 23403949
[TBL] [Abstract][Full Text] [Related]
14. Genome wide DNA copy number analysis in cholangiocarcinoma using high resolution molecular inversion probe single nucleotide polymorphism assay.
Arnold A; Bahra M; Lenze D; Bradtmöller M; Guse K; Gehlhaar C; Bläker H; Heppner FL; Koch A
Exp Mol Pathol; 2015 Oct; 99(2):344-53. PubMed ID: 26260902
[TBL] [Abstract][Full Text] [Related]
15. Association of NRF2 polymorphism with cholangiocarcinoma prognosis in Thai patients.
Khunluck T; Kukongviriyapan V; Puapairoj A; Khuntikeo N; Senggunprai L; Zeekpudsa P; Prawan A
Asian Pac J Cancer Prev; 2014; 15(1):299-304. PubMed ID: 24528044
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor rs4444903 polymorphism and risk of cholangiocarcinoma. A case control study.
Gawish EA; Abdelsameea E; Osheba IS; Mohsen Y; El-Abd MG
Clin Exp Hepatol; 2023 Jun; 9(2):138-145. PubMed ID: 37502431
[TBL] [Abstract][Full Text] [Related]
17. Viral hepatitis B and C infections increase the risks of intrahepatic and extrahepatic cholangiocarcinoma: Evidence from a systematic review and meta-analysis.
Tan JH; Zhou WY; Zhou L; Cao RC; Zhang GW
Turk J Gastroenterol; 2020 Mar; 31(3):246-256. PubMed ID: 32343237
[TBL] [Abstract][Full Text] [Related]
18. Significant association between ABO blood group and pancreatic cancer.
Greer JB; Yazer MH; Raval JS; Barmada MM; Brand RE; Whitcomb DC
World J Gastroenterol; 2010 Nov; 16(44):5588-91. PubMed ID: 21105191
[TBL] [Abstract][Full Text] [Related]
19. A replication study and genome-wide scan of single-nucleotide polymorphisms associated with pancreatic cancer risk and overall survival.
Willis JA; Olson SH; Orlow I; Mukherjee S; McWilliams RR; Kurtz RC; Klein RJ
Clin Cancer Res; 2012 Jul; 18(14):3942-51. PubMed ID: 22665904
[TBL] [Abstract][Full Text] [Related]
20. Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms.
Melum E; Karlsen TH; Schrumpf E; Bergquist A; Thorsby E; Boberg KM; Lie BA
Hepatology; 2008 Jan; 47(1):90-6. PubMed ID: 18023027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
